María José Rabanaque

862 total citations
66 papers, 622 citations indexed

About

María José Rabanaque is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Economics and Econometrics. According to data from OpenAlex, María José Rabanaque has authored 66 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 17 papers in Cardiology and Cardiovascular Medicine and 17 papers in Economics and Econometrics. Recurrent topics in María José Rabanaque's work include Health Systems, Economic Evaluations, Quality of Life (15 papers), Health disparities and outcomes (10 papers) and Blood Pressure and Hypertension Studies (8 papers). María José Rabanaque is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (15 papers), Health disparities and outcomes (10 papers) and Blood Pressure and Hypertension Studies (8 papers). María José Rabanaque collaborates with scholars based in Spain, Denmark and Italy. María José Rabanaque's co-authors include Isabel Aguilar‐Palacio, Sara Malo, Cristina Feja, Patricia Carrera‐Lasfuentes, Lars Bjerrum, Enrica Menditto, José María Abad Díez, Ana Isabel Gil‐Lacruz, Carmen Martos and Carlos Aibar Remón and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Clinical Microbiology.

In The Last Decade

María José Rabanaque

58 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
María José Rabanaque Spain 14 170 155 104 100 86 66 622
Mohamed Hassan Elnaem Malaysia 14 119 0.7× 50 0.3× 63 0.6× 67 0.7× 73 0.8× 90 727
Brook Watts United States 13 363 2.1× 176 1.1× 28 0.3× 92 0.9× 135 1.6× 31 826
Guanyang Zou China 18 313 1.8× 308 2.0× 82 0.8× 248 2.5× 139 1.6× 70 1.0k
Mohamed Azmi Hassali Malaysia 19 212 1.2× 178 1.1× 43 0.4× 72 0.7× 119 1.4× 55 1.0k
Monika Lutters Switzerland 10 94 0.6× 169 1.1× 40 0.4× 49 0.5× 64 0.7× 30 509
Lisa L. Dwyer United States 8 292 1.7× 131 0.8× 43 0.4× 43 0.4× 86 1.0× 15 657
Susan J. Skledar United States 17 125 0.7× 201 1.3× 46 0.4× 116 1.2× 88 1.0× 47 740
Yolanda Agra Spain 19 219 1.3× 185 1.2× 17 0.2× 49 0.5× 47 0.5× 45 1.1k
Joseph Fadare Nigeria 18 244 1.4× 235 1.5× 68 0.7× 110 1.1× 216 2.5× 96 1.3k
Lynn Weekes Australia 13 137 0.8× 104 0.7× 111 1.1× 64 0.6× 144 1.7× 34 558

Countries citing papers authored by María José Rabanaque

Since Specialization
Citations

This map shows the geographic impact of María José Rabanaque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María José Rabanaque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María José Rabanaque more than expected).

Fields of papers citing papers by María José Rabanaque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María José Rabanaque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María José Rabanaque. The network helps show where María José Rabanaque may publish in the future.

Co-authorship network of co-authors of María José Rabanaque

This figure shows the co-authorship network connecting the top 25 collaborators of María José Rabanaque. A scholar is included among the top collaborators of María José Rabanaque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María José Rabanaque. María José Rabanaque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malo, Sara, et al.. (2025). Gender inequalities in prescribing and initiation patterns of guideline-recommended drugs after acute myocardial infarction. BMC Public Health. 25(1). 185–185. 1 indexed citations
2.
3.
Aguilar‐Palacio, Isabel, et al.. (2024). Initiation of lipid‐lowering therapy as primary prevention of cardiovascular disease in the elderly. British Journal of Clinical Pharmacology. 90(10). 2663–2672. 1 indexed citations
4.
Aguilar‐Palacio, Isabel, et al.. (2024). Cohort Profile: The CArdiovascular Risk factors for hEalth Services research (CARhES) cohort study. International Journal of Epidemiology. 53(2). 4 indexed citations
5.
García‐Cárdenas, Victoria, Dyfrig Hughes, Isabel Aguilar‐Palacio, et al.. (2023). Spanish translation of the ABC taxonomy for medication adherence. Research in Social and Administrative Pharmacy. 19(9). 1292–1297. 1 indexed citations
6.
7.
Aguilar‐Palacio, Isabel, et al.. (2022). Effectiveness of Statins for Primary Prevention of Cardiovascular Disease in Low- and Medium-Risk Males: A Causal Inference Approach with Observational Data. Journal of Personalized Medicine. 12(5). 658–658. 1 indexed citations
8.
Aguilar‐Palacio, Isabel, et al.. (2021). Evolution of Cardiovascular Risk Factors in a Worker Cohort: A Cluster Analysis. International Journal of Environmental Research and Public Health. 18(11). 5610–5610. 1 indexed citations
9.
Aguilar‐Palacio, Isabel, et al.. (2021). COVID-19 Inequalities: Individual and Area Socioeconomic Factors (Aragón, Spain). International Journal of Environmental Research and Public Health. 18(12). 6607–6607. 32 indexed citations
10.
11.
Malo, Sara, et al.. (2021). Effect of patient and treatment factors on persistence with antihypertensive treatment: A population-based study. PLoS ONE. 16(1). e0245610–e0245610. 4 indexed citations
12.
Malo, Sara, et al.. (2020). Factors Associated with the Prescribing of High-Intensity Statins. Journal of Clinical Medicine. 9(12). 3850–3850. 3 indexed citations
13.
Aguilar‐Palacio, Isabel, et al.. (2020). New Male Users of Lipid-Lowering Drugs for Primary Prevention of Cardiovascular Disease: The Impact of Treatment Persistence on Morbimortality. A Longitudinal Study. International Journal of Environmental Research and Public Health. 17(20). 7653–7653. 5 indexed citations
14.
Aguilar‐Palacio, Isabel, Sara Malo, Cristina Feja, et al.. (2019). Co-prescription patterns of cardiovascular preventive treatments: a cross-sectional study in the Aragon worker’ health study (Spain). BMJ Open. 9(4). e023571–e023571. 2 indexed citations
15.
Feja, Cristina, et al.. (2018). Use of Non-Steroidal Anti-Inflammatory Drugs and Associated Gastroprotection in a Cohort of Workers. International Journal of Environmental Research and Public Health. 15(9). 1836–1836. 5 indexed citations
16.
Aguilar‐Palacio, Isabel, Sara Malo, Cristina Feja, et al.. (2018). Risk factors control for primary prevention of cardiovascular disease in men: Evidence from the Aragon Workers Health Study (AWHS). PLoS ONE. 13(2). e0193541–e0193541. 10 indexed citations
17.
Aguilar‐Palacio, Isabel, et al.. (2018). Self-rated health in Europe and its determinants: Does generation matter?. International Journal of Public Health. 63(2). 223–232. 31 indexed citations
18.
Malo, Sara, et al.. (2017). Different approaches to the assessment of adherence and persistence with cardiovascular-disease preventive medications. Current Medical Research and Opinion. 33(7). 1329–1336. 50 indexed citations
19.
Rabanaque, María José, et al.. (2014). Patient safety and adverse events related with obstetric care. Archives of Gynecology and Obstetrics. 291(4). 825–830. 17 indexed citations
20.
Remón, Carlos Aibar, et al.. (1999). Evolución de los diseños epidemiológicos de la investigación clínica en España (1975-1994). SHILAP Revista de lepidopterología. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohamed Hassan Elnaem Breakdown of academic impact, for papers by Brook Watts Breakdown of academic impact, for papers by Guanyang Zou Breakdown of academic impact, for papers by Mohamed Azmi Hassali Breakdown of academic impact, for papers by Monika Lutters Breakdown of academic impact, for papers by Lisa L. Dwyer Breakdown of academic impact, for papers by Susan J. Skledar Breakdown of academic impact, for papers by Yolanda Agra Breakdown of academic impact, for papers by Joseph Fadare Breakdown of academic impact, for papers by Lynn Weekes
Rankless by CCL
2026